Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• Lin28A and Lin28B are oncogenes that inhibit let-7 microRNA expression.
• Lin28A recruits Zcchc11 (TUT4) to block let-7 precursor processing by Dicer in the cytoplasm.
• The distinct roles and mechanisms of Lin28A and Lin28B in cancer are not fully understood.

Purpose of the Study:

• To elucidate the distinct mechanisms by which Lin28A and Lin28B repress let-7 microRNA processing.
• To investigate the functional consequences of these distinct mechanisms in human cancers.
• To explore the therapeutic implications of targeting Lin28A and Lin28B pathways.

Main Methods:

• Investigated Lin28B's mechanism of let-7 repression, comparing it to Lin28A.
• Assessed the impact of Zcchc11 depletion on cancer cell tumorigenicity and metastasis in vitro and in vivo.
• Analyzed the expression patterns of Lin28A and Lin28B in human breast and colon tumors.

Main Results:

• Lin28B represses let-7 processing via a Zcchc11-independent nuclear mechanism, sequestering primary let-7 transcripts.
• Zcchc11 depletion's anti-tumor effects were specific to Lin28A-expressing tumors.
• Human tumors predominantly express either Lin28A (in HER2-positive breast cancer) or Lin28B (in triple-negative breast cancer).

Conclusions:

• Lin28A and Lin28B employ distinct mechanisms to regulate let-7 microRNAs, with Lin28A acting cytoplasmically via Zcchc11 and Lin28B acting nuclearly independently of Zcchc11.
• These distinct mechanisms and expression patterns in specific cancer subtypes have significant implications for developing targeted cancer therapies.
• Understanding these differences is crucial for designing effective therapeutic strategies against Lin28-driven cancers.